Marco Ripa
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 9
- HIV/AIDS Research and Interventions 6
- COVID-19 Clinical Research Studies 4
- Antifungal resistance and susceptibility 3
- Virology 11
- HIV Research and Treatment 11
- Co-authors
- Antonella Castagna (24 shared papers)Lorenzo Dagna (6 shared papers)Moreno Tresoldi (4 shared papers)Fabio Ciceri (6 shared papers)Paolo Scarpellini (11 shared papers)Giuseppe A. Ramirez (2 shared papers)Mona‐Rita Yacoub (2 shared papers)Emanuel Della‐Torre (2 shared papers)
- Journals
- Journal of Antimicrobial Chemotherapy (5 papers)Clinical Microbiology and Infection (4 papers)International Journal of Antimicrobial Agents (2 papers)BMJ Open (2 papers)Sexually Transmitted Diseases (1 paper)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Marco Ripa
43 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 107
- Infectious Diseases 433
- Applied Microbiology and Biotechnology 37
- Neurology 228
- Molecular Medicine 79
- Virology 65
Countries citing papers authored by Marco Ripa
This map shows the geographic impact of Marco Ripa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marco Ripa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marco Ripa more than expected).
Fields of papers citing papers by Marco Ripa
This network shows the impact of papers produced by Marco Ripa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marco Ripa. The network helps show where Marco Ripa may publish in the future.
Co-authors
The 25 scholars most cited alongside Marco Ripa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 287 | |
| 2 | 2018 | 204 | |
| 3 | 2020 | 56 | |
| 4 | 2020 | 55 | |
| 5 | 2019 | 54 | |
| 6 | 2018 | 47 | |
| 7 | 2021 | 39 | |
| 8 | 2020 | 39 | |
| 9 | Invasive fungal infections in patients with COVID-19: a review on pathogenesis, epidemiology, clinical features, treatment, and outcomes. | 2021 | 35 |
| 10 | 2019 | 34 | |
| 11 | 2020 | 33 | |
| 12 | 2018 | 26 | |
| 13 | 2023 | 25 | |
| 14 | 2014 | 24 | |
| 15 | 2017 | 19 | |
| 16 | 2018 | 16 | |
| 17 | 2019 | 15 | |
| 18 | 2021 | 14 | |
| 19 | 2015 | 13 | |
| 20 | 2017 | 12 |
About Marco Ripa
Marco Ripa is a scholar working on Infectious Diseases, Virology, Epidemiology, Emergency Medicine and Pharmacology, having authored 47 papers that have together received 1.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (11 papers), HIV/AIDS drug development and treatment (9 papers), HIV/AIDS Research and Interventions (6 papers), Infective Endocarditis Diagnosis and Management (5 papers), HIV-related health complications and treatments (5 papers), COVID-19 Clinical Research Studies (4 papers), Antifungal resistance and susceptibility (3 papers) and Long-Term Effects of COVID-19 (3 papers). The work is most often cited by research in Infectious Diseases (433 citations), Applied Microbiology and Biotechnology (37 citations), Neurology (228 citations), Molecular Medicine (79 citations) and Virology (65 citations). Marco Ripa has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Antonella Castagna, Lorenzo Dagna, Moreno Tresoldi, Fabio Ciceri, Paolo Scarpellini, Giuseppe A. Ramirez, Mona‐Rita Yacoub, Emanuel Della‐Torre, Giulio Cavalli and Giacomo De Luca. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection, International Journal of Antimicrobial Agents, BMJ Open and Sexually Transmitted Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.